TrialAnnals of hematology2021
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.
Jae-Cheol Jo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it